BEHRENS M KATHLEEN (CIK 1211701) reported 11 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy SRPT (16,875 shares), Buy SRPT (10,500 shares), Sell SRPT (6,494 shares), Sell IGMS (22,222 shares), Sell IGMS (330,700 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 16,875 | $0 |
| 2026-01-29 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 10,500 | $143,955 |
| 2026-01-29 | Sarepta Therapeutics, Inc. (SRPT) | Director | Sell | 6,494 | $143,972 |
| 2025-08-14 | IGM Biosciences, Inc. (IGMS) | Director | Sell | 22,222 | $0 |
| 2025-08-14 | IGM Biosciences, Inc. (IGMS) | Director | Sell | 330,700 | $0 |
| 2025-08-14 | IGM Biosciences, Inc. (IGMS) | Director | Sell | 29,807 | $0 |
| 2025-08-14 | IGM Biosciences, Inc. (IGMS) | Director | Sell | 29,806 | $0 |
| 2025-07-02 | IGM Biosciences, Inc. (IGMS) | Director | Buy | 1,471 | $0 |
| 2025-06-23 | MIMEDX GROUP, INC. (MDXG) | Director | Buy | 28,609 | $185,100 |
| 2025-04-02 | IGM Biosciences, Inc. (IGMS) | Director | Buy | 1,471 | $0 |
| 2025-03-11 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 2,383 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05